Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
HKEX:2315
Hong Kong Market
Holding HK:2315?
Track your performance easily

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Similar Stocks

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akeso, Inc.
HK$62.51B
-76.31
91.00%
8 Buy
0 Hold
0 Sell
Strong Buy
TOT BIOPHARM International Co. Ltd.
HK$1.45B
120.51
-6.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Vanov Holdings Company Limited
HK$821.85M
14.78
70.00%
Lai Si Enterprise Holding Ltd.
HK$112.00M
-29.47
-13.85%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$2.47B
-9.38
-56.21%

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
HK:9926
Akeso, Inc.
63.95
26.80
72.14%
HK:1875
TOT BIOPHARM International Co. Ltd.
2.00
0.00
0.00%
HK:2260
Vanov Holdings Company Limited
1.80
0.82
83.67%
HK:2266
Lai Si Enterprise Holding Ltd.
0.30
-0.02
-6.25%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
6.21
-7.97
-56.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis